You searched for "Supporting"

1837 results found

Glaukos marks major milestone as global iStent sales reach 3 million

Glaukos is delighted to announce a major milestone revealing that 3 million iStents have been sold globally since the product first received approval from the FDA in 2012. Today iStent is the global market leader in the MIGs category with...

ABDO responds to GOC research

New research published by the General Optical Council (GOC) shows an increase in public satisfaction in eyecare services.

ABDO to be featured in ITN Business ‘Global Action for Eye Health’ programme

The Association of British Dispensing Opticians (ABDO) is pleased to announce that on World Sight Day (10 October), we will be featuring in an ITN Business news-style programme, ‘Global Action for Eye Health’, aiming to raise awareness and drive action towards improved eye health worldwide.

Retinoblastoma management update (part 1): clinical features, diagnosis and genetics

The first of a two part series, this article will discuss the clinical features, diagnosis and genetic aspects of retinoblastoma. Manoj Parulekar is based at Birmingham Children’s Hospital, one of the two designated national retinoblastoma and paediatric ocular oncology treatment...

The Lancet Global Health Commission on Global Eye Health: vision beyond 2020

Introduction The Lancet Global Health Commission on Global Eye Health was published in 2021 [1]. Drawing on expertise from within and outside the eye health sector, the Commission set out to: inform governments and other stakeholders about the path forward...

Prognostic AI for diabetic retinopathy: Towards the first prospective trial in the UK

Artificial intelligence (AI) is frequently described as having the capacity to dramatically change and improve healthcare. One extensively studied application of AI in ophthalmology involves the diagnosis of diabetic retinopathy (DR) or diabetic maculopathy (DM) using retinal imaging. An emerging...

Moorfields International Corneal & Cataract Symposium 2024

Mr Alexander Ionides & Mr Mark Wilkins, supported by Théa Pharmaceuticals, NuVison Biotherapies, Altomed Ltd. and Daybreak Medical, are pleased to invite you to register your place for the 2024 Moorfields International Corneal & Cataract Symposium! The programme is under construction and will include 14 talks on current Cornea & Cataract topics from Moorfields, UK and international keynote speakers. Confirmed keynote speakers include Dr Soosan Jacob from Dr Agarwal’s Group of Eye Hospitals, Chennai, India, Prof Adnan Tufail and Prof Paul Foster from Moorfields Eye Hospital NHS Foundation Trust. Thea are pleased to be the gold sponsors of this event along with Altomed, NuVision and Daybreak - silver sponsors.

Healthcare insurance influence on surgical outcome

This study sought to determine whether outcomes for simple horizontal strabismus surgery differed for children with supported medical assistance (MA) compared to children with private healthcare insurance, with an assumption of lower socioeconomic status (SES) in the MA group. This...

Mimicked tumour seeding due to asteroid hyalosis

A case report is presented of a patient with treated retinoblastoma (RB) who later developed asteroid hyalosis which mimicked tumour seeding. The case was a 37-year-old male with presenting symptoms of vitreous floaters. A unilateral RB was diagnosed at the...

An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs

Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...

A missed opportunity

Back in 2000 Sir Liam Donaldson wrote a piece of work commissioned by the then Secretary of State for Health entitled “An Organisation with a Memory”. We are now 18 years on and still some of the recommendations from them...

Doing a systematic review: a users’ guide for foundation doctors

Research is increasingly important for junior doctors and systematic reviews (SRs) are a great place to start. Carrying out an SR can help a doctor demonstrate commitment to a specialty, develop research skills and get results quickly. This article aims...